EMPIRICAL study: Patient recruitment reaches halfway point
The EMPIRICAL study (Empirical treatment against cytomegalovirus and tuberculosis in severe pneumonia in HIV-infected infants: a randomized controlled clinical trial) has reached an important milestone: on 8 July 2022, the clinical study randomised patient number 312, which is 50% of the study’s recruitment target of 624. Patients were enrolled in 19 hospitals in Ivory Coast, Malawi, Mozambique, Uganda, Zambia, and Zimbabwe.
The EMPIRICAL study is an EDCTP-funded research project that is evaluating whether empirical treatment against cytomegalovirus and tuberculosis improves the survival of HIV-infected infants with severe pneumonia. For more information, please check the study’s website or follow EMPIRICAL on Twitter.